Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity.
暂无分享,去创建一个
Lucía B. Chemes | T. Gibson | Nicolás Palopoli | N. S. Gonzalez Foutel | Nicolás S. González Foutel | L. Chemes
[1] Nicolas E. Buchler,et al. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family , 2017, Proceedings of the National Academy of Sciences.
[2] F. Dick,et al. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family. , 2016, Journal of molecular biology.
[3] N. Dyson. RB1: a prototype tumor suppressor and an enigma , 2016, Genes & development.
[4] S. Michnick,et al. Evolution of domain–peptide interactions to coadapt specificity and affinity to functional diversity , 2016, Proceedings of the National Academy of Sciences.
[5] S. Haferkamp,et al. Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells , 2016, International journal of cancer.
[6] Toby J. Gibson,et al. ELM 2016—data update and new functionality of the eukaryotic linear motif resource , 2015, Nucleic Acids Res..
[7] Alan M. Moses,et al. Short linear motifs – ex nihilo evolution of protein regulation , 2015, Cell Communication and Signaling.
[8] I. E. Sánchez,et al. Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions. , 2015, Current opinion in structural biology.
[9] L. Litovchick,et al. Structural mechanisms of DREAM complex assembly and regulation , 2015, Genes & development.
[10] J. Ross,et al. Structural and functional characterization of the acidic region from the RIZ tumor suppressor. , 2015, Biochemistry.
[11] O. Fedorov,et al. Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor , 2014, Proceedings of the National Academy of Sciences.
[12] M. Madan Babu,et al. A million peptide motifs for the molecular biologist. , 2014, Molecular cell.
[13] Aidan Budd,et al. Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation. , 2014, Chemical reviews.
[14] T. Dobner,et al. High-Affinity Rb Binding, p53 Inhibition, Subcellular Localization, and Transformation by Wild-Type or Tumor-Derived Shortened Merkel Cell Polyomavirus Large T Antigens , 2013, Journal of Virology.
[15] Frederick A. Dick,et al. Molecular mechanisms underlying RB protein function , 2013, Nature Reviews Molecular Cell Biology.
[16] Lucía B. Chemes,et al. Sequence Evolution of the Intrinsically Disordered and Globular Domains of a Model Viral Oncoprotein , 2012, PloS one.
[17] I. E. Sánchez,et al. Evolution of linear motifs within the papillomavirus E7 oncoprotein. , 2012, Journal of molecular biology.
[18] Katja Luck,et al. The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains , 2012, FEBS letters.
[19] Joan Teyra,et al. Elucidation of the binding preferences of peptide recognition modules: SH3 and PDZ domains , 2012, FEBS letters.
[20] Greg L. Hura,et al. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. , 2012, Genes & development.
[21] A. Davidson,et al. Distinct Peptide Binding Specificities of Src Homology 3 (SH3) Protein Domains Can Be Determined by Modulation of Local Energetics across the Binding Interface* , 2012, The Journal of Biological Chemistry.
[22] Zohar Itzhaki,et al. A Dynamic View of Domain-Motif Interactions , 2012, PLoS Comput. Biol..
[23] Norman E. Davey,et al. Attributes of short linear motifs. , 2012, Molecular bioSystems.
[24] I. E. Sánchez,et al. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target. , 2011, Journal of molecular biology.
[25] T. Sixma,et al. Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain , 2011, EMBO reports.
[26] Norman E. Davey,et al. How viruses hijack cell regulation. , 2011, Trends in biochemical sciences.
[27] Young Sun,et al. p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis , 2010, Oncogene.
[28] Shili Duan,et al. Recognition and Specificity Determinants of the Human Cbx Chromodomains* , 2010, The Journal of Biological Chemistry.
[29] F. Dick,et al. An Overlapping Kinase and Phosphatase Docking Site Regulates Activity of the Retinoblastoma Protein , 2010, Nature Structural &Molecular Biology.
[30] Brett W. Engelmann,et al. SH2 Domains Recognize Contextual Peptide Sequence Information to Determine Selectivity* , 2010, Molecular & Cellular Proteomics.
[31] L. Aravind,et al. Diversity and evolution of chromatin proteins encoded by DNA viruses. , 2010, Biochimica et biophysica acta.
[32] Lucía B. Chemes,et al. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein , 2010, The FEBS journal.
[33] Toby J. Gibson,et al. Evidence for the Concerted Evolution between Short Linear Protein Motifs and Their Flanking Regions , 2009, PloS one.
[34] G. Montelione,et al. Crystal structure of human retinoblastoma binding protein 9 , 2009, Proteins.
[35] Richard J. Edwards,et al. Masking residues using context-specific evolutionary conservation significantly improves short linear motif discovery , 2009, Bioinform..
[36] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[37] Patrick Aloy,et al. Contextual Specificity in Peptide-Mediated Protein Interactions , 2008, PloS one.
[38] N. Dyson,et al. RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. , 2008, Genes & development.
[39] Ronen Marmorstein,et al. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. , 2007, Genes & development.
[40] F. Dick. Structure-function analysis of the retinoblastoma tumor suppressor protein – is the whole a sum of its parts? , 2007, Cell Division.
[41] M. Kitagawa,et al. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage , 2007, The EMBO journal.
[42] Frederick A. Dick,et al. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit , 2007, Nature Cell Biology.
[43] Walter Hunziker,et al. Convergent and Divergent Ligand Specificity among PDZ Domains of the LAP and Zonula Occludens (ZO) Families* , 2006, Journal of Biological Chemistry.
[44] Mahavir Singh,et al. Molecular Determinants for the Complex Formation between the Retinoblastoma Protein and LXCXE Sequences* , 2005, Journal of Biological Chemistry.
[45] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[46] Bostjan Kobe,et al. Structural Basis for the Specificity of Bipartite Nuclear Localization Sequence Binding by Importin-α* , 2003, Journal of Biological Chemistry.
[47] M. Burghammer,et al. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] Ivo Tews,et al. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. , 2002, Biochemistry.
[49] Jeong Ho Chang,et al. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. , 2002, Genes & development.
[50] S. Reed,et al. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). , 2002, Genes & development.
[51] S. Schreiber,et al. Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation* , 2001, The Journal of Biological Chemistry.
[52] Q. Dou,et al. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis , 2001, Oncogene.
[53] Yunje Cho,et al. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen , 2001, The EMBO journal.
[54] N. Dyson,et al. Retinoblastoma protein partners. , 2001, Advances in cancer research.
[55] Jie-Oh Lee,et al. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 , 1998, Nature.
[56] P. Branton,et al. Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein , 1996, Journal of virology.
[57] K. Helin,et al. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes , 1993, Molecular and cellular biology.
[58] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[59] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[60] C. Anderson,et al. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. , 1991, The EMBO journal.
[61] R. Peters,et al. The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T‐antigen. , 1991, The EMBO journal.
[62] V. Garsky,et al. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. , 1990, The Journal of biological chemistry.